The Role of Serotonin in Alcohol's Effects on the Brain

Total Page:16

File Type:pdf, Size:1020Kb

The Role of Serotonin in Alcohol's Effects on the Brain The Role of Serotonin in Alcohol’s Effects on the Brain David M. Lovinger, Ph.D. Serotonin is an important brain chemical that acts as a neurotransmitter Department of Molecular to communicate information among nerve cells. Serotonin’s actions have Physiology and Biophysics been linked to alcohol’s effects on the brain and to alcohol abuse. Vanderbilt University School of Medicine Alcoholics and experimental animals that consume large quantities of Nashville, TN 37232-0615 alcohol show evidence of differences in brain serotonin levels compared with nonalcoholics. Both short- and long-term alcohol exposures also affect the serotonin receptors that convert the chemical signal produced by serotonin into functional changes in the signal-receiving cell. Drugs that act on these receptors alter alcohol consumption in both humans and animals. Serotonin, along with other neurotransmitters, also may contribute to alcohol’s intoxicating and rewarding effects, and abnormalities in the brain’s serotonin system appear to play an important role in the brain processes underlying alcohol abuse. Neurotransmitters are chemicals This article reviews serotonin’s plays an important role in the control that allow signal transmission, and function in the brain and the conse- of emotions, and the nucleus accum- thus communication, among nerve quences of acute and chronic alcohol bens, a brain area involved in con- cells (i.e., neurons). One neurotrans- consumption on serotonin-mediated trolling the motivation to perform mitter used by many neurons (i.e., serotonergic) signal transmis- certain behaviors, including the throughout the brain is serotonin, sion. In addition, the article summa- abuse of alcohol and other drugs. In also known as 5-hydroxytryptamine rizes recent findings indicating that these brain regions, the axon endings (5-HT). Serotonin released by the serotonin may play a pivotal role in of the serotonergic neurons secrete signal-emitting neuron subtly alters the development of alcohol abuse. serotonin when activated. The the function of the signal-receiving neurotransmitter then traverses the neurons in a process called neuro- Serotonin’s Functions small space separating the neurons modulation. For example, in some in the Brain from each other (i.e., the synaptic neurons serotonin alters the rate at cleft) and binds to specialized dock- which the cells produce the electrical Serotonin is produced in and re- ing molecules (i.e., receptors) on the signals (i.e., action potentials) used leased from neurons that originate recipient cell. for relaying information within the within discrete regions, or nuclei, in The binding of serotonin to its cells, whereas in other neurons it the brain (1). Many serotonergic receptors initiates a series of bio- modulates the release of other neuro- neurons are located at the base of the chemical events that converts the ex- transmitters. Although serotonin’s brain in an area known as the raphe tracellular, chemical signal into an effect on individual neurons can be nucleus, which influences brain intracellular signal in the recipient rather modest, its overall effect on functions related to attention, emo- cell. For example, the interaction of the neurons in a given brain area can tion, and motivation. The axons of serotonin with one type of receptor substantially influence brain func- the neurons in the raphe nucleus ex- stimulates the formation of small tions such as learning and memory, tend, or project, throughout the molecules (i.e., second messengers) perception of the environment, brain to numerous regions with di- within the cell. Second messengers mood states, and responses to alco- verse functions. These brain regions interact with other proteins to acti- hol and other drugs of abuse. include the amygdala, an area that vate various cellular functions, such 23 Current Separations 18:1 (1999) F1 products generated after the neuro- Activation of serotonin transmitter has been removed from receptors (5-HTR) produces multiple effects the synapse (i.e., serotonin metabo- on neurons. Serotonin 5-HT + lites). The concentrations of these (5-HT) can bind to receptors that activate metabolites, which can be deter- proteins within the cell + 5-HT3 R mined from samples of blood, urine, called G proteins. 5-HT Activation of these Ion or the fluid that bathes the brain and proteins, in turn, affects channel spinal cord (i.e., cerebrospinal fluid ion channels in the cell membranes and [CSF]) (3,4,5), provide an indirect induces the formation Direct measure of changes in the overall of signaling molecules 5-HTR G protein activation serotonin level in the brain. (i.e., second-messenger of neuron molecules). Second messengers also can act Second-messenger molecules on ion channels or travel Acute Alcohol Effects on the to the nucleus to alter Brain’s Serotonin Systems gene expression. Other Cell serotonin-activated nucleus receptors (i.e., the 5-HT Alcohol interacts with serotoner- receptors) double as ion3 channels. Their activation gic synaptic transmission in the brain directly excites neurons. in several ways. Even single-episode (i.e., acute) alcohol exposure alters various aspects of serotonin’s synap- T1 tic functions. In humans, for exam- Serotonin receptor Receptor Potential Role in the ple, the levels of serotonin subtypes and their Subtypes Development of Alcohol Abuse potential roles in the metabolites in the urine and blood development of May control consummatory behavior, including alcohol increase after a single drinking ses- alcohol abuse. 5-HT1A consumption. sion, indicating increased serotonin May contribute to alcohol’s intoxicating effects. May play release in the nervous system (3). 5-HT 1B a role in development of tolerance to alcohol’s effects. This increase may reflect enhanced signal transmission at serotonergic May contribute to development of alcohol withdrawal 5-HT 2 symptoms. May play a role in alcohol’s rewarding effects. synapses. Animal studies also have found that acute alcohol exposure May regulate alcohol consumption. May contribute to 5-HT3 elevates serotonin levels within the alcohol’s rewarding effects. brain (6,7), suggesting either that more serotonin is released from the serotonergic axons or that the neuro- as changes in the cell’s electrical ac- cells’ exposure to serotonin, thereby transmitter is cleared more slowly tivity or in the activity of certain disrupting the exquisite timing of from the synapses. For example, in- genes (see F1). These changes can nerve signals within the brain. The creased serotonin release after acute result either in the inhibition or the net result of such disruptions is ab- alcohol exposure has been observed excitation of the signal-receiving normal brain activity, which can lead in brain regions that control the con- neuron, depending on the cell af- to psychological problems or mental sumption or use of numerous sub- fected. Through these mechanisms, illness. One prominent example of stances, including many drugs of serotonin can influence mood states; psychological disorder that appears abuse (7). Researchers currently are thinking patterns; and even behav- to involve inappropriate serotonin trying to determine the exact mecha- iors, such as alcohol drinking. use in the brain is depression (2); nisms underlying the alcohol-in- Serotonin’s actions at the syn- some of the most effective antide- duced changes. For example, they apses normally are tightly regulated pressant medications act on the sero- are investigating whether the net in- by proteins called serotonin trans- tonin transporters to prolong the crease in synaptic serotonin levels porters, which remove the neuro- neurotransmitter’s activity. results from alcohol’s direct actions transmitter from the synaptic cleft Researchers currently cannot di- on molecules involved in serotonin after a short period of time by trans- rectly measure serotonin concentra- release and uptake or from more in- porting it back into the signal-emit- tions in the human brain or within the direct alcohol effects. ting cell. Consequently, serotonin synapses in laboratory animals. To Alcohol also interferes with the can affect neighboring neurons only gain information about serotonin function of serotonin receptors. Sev- for a short period of time. Any inter- levels in the brain, physicians and eral types of these receptors exist, ference with serotonin transporter researchers have measured the con- including the 5-HT1A, 5-HT1B,5- function extends or diminishes the centrations of serotonin breakdown HT2 and 5-HT3 receptors (see T1). Current Separations 18:1 (1999) 24 When activated by serotonin bind- process, also called tolerance devel- ciated with impulsive violence and ing, the 5-HT3 receptor rapidly in- opment, presumably is a mechanism other behavioral disorders (5). creases neuron activity by to re-establish normal cell function, generating electrical signals (8). or homeostasis, in response to con- Serotonin’s Role in the Acute alcohol exposure enhances the tinuous alcohol-induced alterations. Development of Alcohol electrical signals generated by the For example, if alcohol exposure in- Abuse 5-HT3 receptor. This change in re- hibits the function of a neurotrans- ceptor function likely results from mitter receptor, the cells may Two lines of evidence suggest alcohol’s direct action on the recep- attempt to compensate for continu- that serotonin may be a key contribu- tor protein or molecules closely as- ous inhibition by increasing the re- tor to the brain dysfunction that leads sociated with
Recommended publications
  • Serotonin's Role in Alcohol's Effects on the Brain
    NEUROTRANSMITTER REVIEW IMPERATO, A., AND DI CHIARA, G. Preferential stimulation of dopamine release in the nucleus accumbens of freely moving rats by ethanol. Journal SEROTONIN’S ROLE IN ALCOHOL’S of Pharmacology and Experimental Therapeutics 239:219–228, 1986. EFFECTS ON THE BRAIN KITAI, S.T., AND SURMEIER, D.J. Cholinergic and dopaminergic modula- tion of potassium conductances in neostriatal neurons. Advances in David M. Lovinger, Ph.D. Neurology 60:40–52, 1993. LE MOINE, C.; NORMAND, E.; GUITTENY, A.F.; FOUQUE, B.; TEOULE, R.; AND BLOCH, B. Dopamine receptor gene expression by enkephalin Serotonin is an important brain chemical that acts as a neurons in rat forebrain. Proceedings of the National Academy of Sciences neurotransmitter to communicate information among USA 87:230–234, 1990. nerve cells. Serotonin’s actions have been linked to al- LE MOINE, C.; NORMAND, E.; AND BLOCH, B. Phenotypical character- cohol’s effects on the brain and to alcohol abuse. ization of the rat striatal neurons expressing the D1 dopamine receptor Alcoholics and experimental animals that consume gene. Proceedings of the National Academy of Sciences USA 88: large quantities of alcohol show evidence of differences 4205–4209, 1991. in brain serotonin levels compared with nonalcoholics. LYNESS, W.H., AND SMITH F.L. Influence of dopaminergic and sero- Both short- and long-term alcohol exposure also affect tonergic neurons on intravenous ethanol self-administration in the rat. the serotonin receptors that convert the chemical sig- Pharmacology and Biochemistry of Behavior 42:187–192, 1992. nal produced by serotonin into functional changes in the signal-receiving cell.
    [Show full text]
  • The Serotonergic System in Migraine Andrea Rigamonti Domenico D’Amico Licia Grazzi Susanna Usai Gennaro Bussone
    J Headache Pain (2001) 2:S43–S46 © Springer-Verlag 2001 MIGRAINE AND PATHOPHYSIOLOGY Massimo Leone The serotonergic system in migraine Andrea Rigamonti Domenico D’Amico Licia Grazzi Susanna Usai Gennaro Bussone Abstract Serotonin (5-HT) and induce migraine attacks. Moreover serotonin receptors play an impor- different pharmacological preventive tant role in migraine pathophysiolo- therapies (pizotifen, cyproheptadine gy. Changes in platelet 5-HT content and methysergide) are antagonist of are not casually related, but they the same receptor class. On the other may reflect similar changes at a neu- side the activation of 5-HT1B-1D ronal level. Seven different classes receptors (triptans and ergotamines) of serotoninergic receptors are induce a vasocostriction, a block of known, nevertheless only 5-HT2B-2C neurogenic inflammation and pain M. Leone • A. Rigamonti • D. D’Amico and 5HT1B-1D are related to migraine transmission. L. Grazzi • S. Usai • G. Bussone (౧) syndrome. Pharmacological evi- C. Besta National Neurological Institute, Via Celoria 11, I-20133 Milan, Italy dences suggest that migraine is due Key words Serotonin • Migraine • e-mail: [email protected] to an hypersensitivity of 5-HT2B-2C Triptans • m-Chlorophenylpiperazine • Tel.: +39-02-2394264 receptors. m-Chlorophenylpiperazine Pathogenesis Fax: +39-02-70638067 (mCPP), a 5-HT2B-2C agonist, may The 5-HT receptor family is distinguished from all other 5- Introduction 1 HT receptors by the absence of introns in the genes; in addi- tion all are inhibitors of adenylate cyclase [1]. Serotonin (5-HT) and serotonin receptors play an important The 5-HT1A receptor has a high selective affinity for 8- role in migraine pathophysiology.
    [Show full text]
  • THE USE of MIRTAZAPINE AS a HYPNOTIC O Uso Da Mirtazapina Como Hipnótico Francisca Magalhães Scoralicka, Einstein Francisco Camargosa, Otávio Toledo Nóbregaa
    ARTIGO ESPECIAL THE USE OF MIRTAZAPINE AS A HYPNOTIC O uso da mirtazapina como hipnótico Francisca Magalhães Scoralicka, Einstein Francisco Camargosa, Otávio Toledo Nóbregaa Prescription of approved hypnotics for insomnia decreased by more than 50%, whereas of antidepressive agents outstripped that of hypnotics. However, there is little data on their efficacy to treat insomnia, and many of these medications may be associated with known side effects. Antidepressants are associated with various effects on sleep patterns, depending on the intrinsic pharmacological properties of the active agent, such as degree of inhibition of serotonin or noradrenaline reuptake, effects on 5-HT1A and 5-HT2 receptors, action(s) at alpha-adrenoceptors, and/or histamine H1 sites. Mirtazapine is a noradrenergic and specific serotonergic antidepressive agent that acts by antagonizing alpha-2 adrenergic receptors and blocking 5-HT2 and 5-HT3 receptors. It has high affinity for histamine H1 receptors, low affinity for dopaminergic receptors, and lacks anticholinergic activity. In spite of these potential beneficial effects of mirtazapine on sleep, no placebo-controlled randomized clinical trials of ABSTRACT mirtazapine in primary insomniacs have been conducted. Mirtazapine was associated with improvements in sleep on normal sleepers and depressed patients. The most common side effects of mirtazapine, i.e. dry mouth, drowsiness, increased appetite and increased body weight, were mostly mild and transient. Considering its use in elderly people, this paper provides a revision about studies regarding mirtazapine for sleep disorders. KEYWORDS: sleep; antidepressive agents; sleep disorders; treatment� A prescrição de hipnóticos aprovados para insônia diminuiu em mais de 50%, enquanto de antidepressivos ultrapassou a dos primeiros.
    [Show full text]
  • MDMA) Cause Selective Ablation of Serotonergic Axon Terminals in Forebrain: Lmmunocytochemical Evidence for Neurotoxicity
    The Journal of Neuroscience, August 1988, 8(8): 2788-2803 Methylenedioxyamphetamine (MDA) and Methylenedioxymetham- phetamine (MDMA) Cause Selective Ablation of Serotonergic Axon Terminals in Forebrain: lmmunocytochemical Evidence for Neurotoxicity E. O’Hearn,” G. Battaglia, lab E. B. De Souza,’ M. J. Kuhar,’ and M. E. Molliver Departments of Neuroscience, and Neurology, The Johns Hopkins University School of Medicine, Baltimore, Maryland 21205, and ‘Neuroscience Branch, Addiction Research Center, National Institute on Drug Abuse, Baltimore, Maryland 21224 The psychotropic amphetamine derivatives 3,4-methylene- The synthetic amphetamine derivatives 3,4-methylenedioxy- dioxyamphetamine (MDA) and 3,4-methylenedioxymetham- amphetamine (MDA) and 3,4-methylenedioxymethamphet- phetamine (MDMA) have been used for recreational and amine (MDMA) are potent mood-altering drugs that have at- therapeutic purposes in man. In rats, these drugs cause large tained public interest (Seymour, 1986) due to their widespread, reductions in brain levels of serotonin (5HT). This study self-administration by young adults (e.g., Klein, 1985). These employs immunocytochemistry to characterize the neuro- drugs have also been proposed for medical use in psychotherapy toxic effects of these compounds upon monoaminergic neu- because they produce augmentation of mood and enhanced in- rons in the rat brain. Two weeks after systemic administra- sight (Naranjo et al., 1967; Yensen et al., 1976; Di Leo, 198 1; tion of MDA or MDMA (20 mg/kg, s.c., twice daily for 4 d), Greer and Tolbert, 1986; Grinspoon and Bakalar, 1986). How- there is profound loss of serotonergic (5HT) axons through- ever, concern has been raised about the safety of these com- out the forebrain; catecholamine axons are completely pounds based on evidence that they may be toxic to brain seroto- spared.
    [Show full text]
  • 5-HT3 Receptor Antagonists in Neurologic and Neuropsychiatric Disorders: the Iceberg Still Lies Beneath the Surface
    1521-0081/71/3/383–412$35.00 https://doi.org/10.1124/pr.118.015487 PHARMACOLOGICAL REVIEWS Pharmacol Rev 71:383–412, July 2019 Copyright © 2019 by The Author(s) This is an open access article distributed under the CC BY-NC Attribution 4.0 International license. ASSOCIATE EDITOR: JEFFREY M. WITKIN 5-HT3 Receptor Antagonists in Neurologic and Neuropsychiatric Disorders: The Iceberg Still Lies beneath the Surface Gohar Fakhfouri,1 Reza Rahimian,1 Jonas Dyhrfjeld-Johnsen, Mohammad Reza Zirak, and Jean-Martin Beaulieu Department of Psychiatry and Neuroscience, Faculty of Medicine, CERVO Brain Research Centre, Laval University, Quebec, Quebec, Canada (G.F., R.R.); Sensorion SA, Montpellier, France (J.D.-J.); Department of Pharmacodynamics and Toxicology, School of Pharmacy, Mashhad University of Medical Sciences, Mashhad, Iran (M.R.Z.); and Department of Pharmacology and Toxicology, University of Toronto, Toronto, Ontario, Canada (J.-M.B.) Abstract. ....................................................................................384 I. Introduction. ..............................................................................384 II. 5-HT3 Receptor Structure, Distribution, and Ligands.........................................384 A. 5-HT3 Receptor Agonists .................................................................385 B. 5-HT3 Receptor Antagonists. ............................................................385 Downloaded from 1. 5-HT3 Receptor Competitive Antagonists..............................................385 2. 5-HT3 Receptor
    [Show full text]
  • Alcohol Dependence and Withdrawal Impair Serotonergic Regulation Of
    Research Articles: Cellular/Molecular Alcohol dependence and withdrawal impair serotonergic regulation of GABA transmission in the rat central nucleus of the amygdala https://doi.org/10.1523/JNEUROSCI.0733-20.2020 Cite as: J. Neurosci 2020; 10.1523/JNEUROSCI.0733-20.2020 Received: 30 March 2020 Revised: 8 July 2020 Accepted: 14 July 2020 This Early Release article has been peer-reviewed and accepted, but has not been through the composition and copyediting processes. The final version may differ slightly in style or formatting and will contain links to any extended data. Alerts: Sign up at www.jneurosci.org/alerts to receive customized email alerts when the fully formatted version of this article is published. Copyright © 2020 the authors 1 Alcohol dependence and withdrawal impair serotonergic regulation of GABA 2 transmission in the rat central nucleus of the amygdala 3 Abbreviated title: Alcohol dependence impairs CeA regulation by 5-HT 4 Sophia Khom, Sarah A. Wolfe, Reesha R. Patel, Dean Kirson, David M. Hedges, Florence P. 5 Varodayan, Michal Bajo, and Marisa Roberto$ 6 The Scripps Research Institute, Department of Molecular Medicine, 10550 N. Torrey Pines 7 Road, La Jolla CA 92307 8 $To whom correspondence should be addressed: 9 Dr. Marisa Roberto 10 Department of Molecular Medicine 11 The Scripps Research Institute 12 10550 N. Torrey Pines Road, La Jolla, CA 92037 13 Tel: (858) 784-7262 Fax: (858) 784-7405 14 Email: [email protected] 15 16 Number of pages: 30 17 Number of figures: 7 18 Number of tables: 2 19 Number of words (Abstract): 250 20 Number of words (Introduction): 650 21 Number of words (Discussion): 1500 22 23 The authors declare no conflict of interest.
    [Show full text]
  • 5-HT2C Agonists Modulate Schizophrenia-Like Behaviors in Mice
    Neuropsychopharmacology (2017) 42, 2163–2177 © 2017 American College of Neuropsychopharmacology. All rights reserved 0893-133X/17 www.neuropsychopharmacology.org 5-HT2C Agonists Modulate Schizophrenia-Like Behaviors in Mice 1 1,2 3,7 4 1 Vladimir M Pogorelov , Ramona M Rodriguiz , Jianjun Cheng , Mei Huang , Claire M Schmerberg , 4 5 3 ,1,2,6 Herbert Y Meltzer , Bryan L Roth , Alan P Kozikowski and William C Wetsel* 1 2 Department of Psychiatry and Behavioral Sciences, Duke University Medical Center, Durham, NC, USA; Mouse Behavioral and Neuroendocrine 3 Analysis Core Facility, Duke University Medical Center, Durham, NC, USA; Drug Discovery Program, Department of Medicinal Chemistry and 4 Pharmacognosy, College of Pharmacy, University of Illinois, Chicago, IL, USA; Department of Psychiatry and Pharmacology, Northwestern University Feinberg School of Medicine, Chicago, IL, USA; 5National Institute of Mental Health Psychoactive Drug Screening Program, Department of Pharmacology and Division of Chemical Biology and Medicinal Chemistry, University of North Carolina Chapel Hill Medical School, Chapel Hill, NC, 6 USA; Departments of Cell Biology and Neurobiology, Duke University Medical Center, Durham, NC, USA All FDA-approved antipsychotic drugs (APDs) target primarily dopamine D2 or serotonin (5-HT2A) receptors, or both; however, these medications are not universally effective, they may produce undesirable side effects, and provide only partial amelioration of negative and cognitive symptoms. The heterogeneity of pharmacological responses in schizophrenic patients suggests that additional drug targets may be effective in improving aspects of this syndrome. Recent evidence suggests that 5-HT receptors may be a promising target for 2C schizophrenia since their activation reduces mesolimbic nigrostriatal dopamine release (which conveys antipsychotic action), they are expressed almost exclusively in CNS, and have weight-loss-promoting capabilities.
    [Show full text]
  • Repeated Exposure to MDMA Triggers Long-Term Plasticity of Noradrenergic and Serotonergic Neurons
    Molecular Psychiatry (2014) 19, 823–833 & 2014 Macmillan Publishers Limited All rights reserved 1359-4184/14 www.nature.com/mp ORIGINAL ARTICLE Repeated exposure to MDMA triggers long-term plasticity of noradrenergic and serotonergic neurons C Lanteri1,2,3, EL Doucet1,2,3, SJ Herna´ndez Vallejo4, G Godeheu1,2,3, A-C Bobadilla1,2,3, L Salomon5, L Lanfumey6 and J-P Tassin1,2,3 3,4-Methylenedioxymethamphetamine (MDMA or ‘ecstasy’) is a psychostimulant drug, widely used recreationally among young people in Europe and North America. Although its neurotoxicity has been extensively described, little is known about its ability to strengthen neural circuits when administered in a manner that reproduces human abuse (i.e. repeated exposure to a low dose). C57BL/6J mice were repeatedly injected with MDMA (10 mg kg À 1, intraperitoneally) and studied after a 4-day or a 1-month withdrawal. We show, using in vivo microdialysis and locomotor activity monitoring, that repeated injections of MDMA induce a long-term sensitization of noradrenergic and serotonergic neurons, which correlates with behavioral sensitization. The development of this phenomenon, which lasts for at least 1 month after withdrawal, requires repeated stimulation of a1B-adrenergic and 5-hydroxytryptamine (5-HT)2A receptors. Moreover, behavioral and neuroendocrine assays indicate that hyper-reactivity of noradrenergic and serotonergic networks is associated with a persistent desensitization of somatodendritic a2A-adrenergic and 5-HT1A autoreceptor function. Finally, molecular analysis including radiolabeling, western blot and quantitative reverse transcription-polymerase chain reaction reveals that mice repeatedly treated with MDMA exhibit normal a2A-adrenergic and 5-HT1A receptor binding, but a long-lasting downregulation of Gai proteins expression in both locus coeruleus and dorsal raphe nucleus.
    [Show full text]
  • Alcohol Dependence and Withdrawal Impair Serotonergic Regulation of GABA Transmission in the Rat Central Nucleus of the Amygdala
    6842 • The Journal of Neuroscience, September 2, 2020 • 40(36):6842–6853 Cellular/Molecular Alcohol Dependence and Withdrawal Impair Serotonergic Regulation of GABA Transmission in the Rat Central Nucleus of the Amygdala Sophia Khom, Sarah A. Wolfe, Reesha R. Patel, Dean Kirson, David M. Hedges, Florence P. Varodayan, Michal Bajo, and Marisa Roberto Department of Molecular Medicine, The Scripps Research Institute, La Jolla, California 92307 Excessive serotonin (5-HT) signaling plays a critical role in the etiology of alcohol use disorder. The central nucleus of the amygdala (CeA) is a key player in alcohol-dependence associated behaviors. The CeA receives dense innervation from the dor- sal raphe nucleus, the major source of 5-HT, and expresses 5-HT receptor subtypes (e.g., 5-HT2C and 5-HT1A) critically linked to alcohol use disorder. Notably, the role of 5-HT regulating rat CeA activity in alcohol dependence is poorly investi- gated. Here, we examined neuroadaptations of CeA 5-HT signaling in adult, male Sprague Dawley rats using an established model of alcohol dependence (chronic intermittent alcohol vapor exposure), ex vivo slice electrophysiology and ISH. 5-HT increased frequency of sIPSCs without affecting postsynaptic measures, suggesting increased CeA GABA release in naive rats. In dependent rats, this 5-HT-induced increase of GABA release was attenuated, suggesting blunted CeA 5-HT sensitivity, which partially recovered in protracted withdrawal (2 weeks). 5-HT increased vesicular GABA release in naive and dependent rats but had split effects (increase and decrease) after protracted withdrawal indicative of neuroadaptations of presynaptic 5- HT receptors. Accordingly, 5-HT abolished spontaneous neuronal firing in naive and dependent rats but had bidirectional effects in withdrawn.
    [Show full text]
  • 5-HT Receptors Review
    Neuronal 5-HT Receptors and SERT Nicholas M. Barnes1 and John F. Neumaier2 1Cellular and Molecular Neuropharmacology Research Group, Section of Neuropharmacology and Neurobiology, Clinical and Experimental Medicine, The Medical School, University of Birmingham, Edgbaston, Birmingham B15 2TT UK and 2Department of Psychiatry, University of Washington, Seattle, WA 98104 USA. Correspondence: [email protected] and [email protected] Nicholas Barnes is Professor of Neuropharmacology at the University of Birmingham Medical School, and focuses on serotonin receptors and the serotonin transporter. John Neumaier is Professor of Psychiatry and Behavioural Sciences and Director of the Division of Neurosciences at the University of Washington. His research concerns the role of serotonin receptors in emotional behavior. Contents Introduction Introduction ........................................................................ 1 5-hydroxytryptamine (5-HT, serotonin) is an ancient biochemical manipulated through evolution to be DRIVING RESEARCH FURTHER The 5-HT1 Receptor Family ............................................... 1 utilized extensively throughout the animal and plant kingdoms. Mammals employ 5-HT as a 5-HT Receptors ............................................................ 2 1A neurotransmitter within the central and peripheral nervous systems, and also as a local hormone in 5-HT Receptors ............................................................ 2 1B numerous other tissues, including the gastrointestinal tract, the cardiovascular
    [Show full text]
  • Antidepressants: Mechanism of Action, Toxicity and Possible Amelioration
    Journal of Applied Biotechnology & Bioengineering Research Article Open Access Antidepressants: mechanism of action, toxicity and possible amelioration Abstract Volume 3 Issue 5 - 2017 Depression being a state of sadness may be defined as a psychoneurotic disorder Khushboo, Sharma B characterised by mental and functional activity, sadness, reduction in activity, Department of Biochemistry, University of Allahabad, India difficulty in thinking, loss of concentration, perturbations in appetite, sleeping, and feelings of dejection, hopelessness and generation of suicidal tendencies. It Correspondence: B Sharma, Department of Biochemistry, is a common and recurrent disorder causing significant morbidity and mortality University of Allahabad, Allahabad 211002, UP, India, worldwide. The antidepressant compounds used against depression are reported to Email [email protected] be used also for treating pain, anxiety syndromes etc. They have been grouped in five different categories such as Received: June 29, 2017 | Published: September 01, 2017 i. Tricyclic antidepressants (TCAs) ii. Selective serotonin-reuptake inhibitors (SSRIs) iii. Monoamine oxidase inhibitors (MAOIs) iv. Serotonin-norepinephrine reuptake inhibitor (SNRI) and v. Non-TCA antidepressants based on their mode of action. Most of the antidepressants have been reported to possess adverse effects on the health of users. The present review article focuses on an updated current of antidepressants, their mechanism of actions, pathophysiology of these compounds, their side effects and
    [Show full text]
  • Anafranil (Clomipramine Hydrochloride) Tablets 1 Name of the Medicine 2 Qualitative and Quant
    AUSTRALIAN PRODUCT INFORMATION – ANAFRANIL (CLOMIPRAMINE HYDROCHLORIDE) TABLETS 1 NAME OF THE MEDICINE Clomipramine hydrochloride 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Each tablet contains 25 mg clomipramine hydrochloride. Lactose and sucrose Anafranil tablets contain lactose and sucrose. Patients with rare hereditary problems of galactose intolerance, fructose intolerance, severe lactase deficiency, sucrase-isomaltase insufficiency or glucose-galactose malabsorption should not take Anafranil tablets. For the full list of excipients, see Section 6.1 List of excipients. 3 PHARMACEUTICAL FORM Tablet 4 CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS • Major depression. • Obsessive-compulsive disorders and phobias in adults. • Cataplexy associated with narcolepsy. 4.2 DOSE AND METHOD OF ADMINISTRATION General The dosage should be determined individually and adapted to the patient's condition. Doses should be kept as low as possible and increased cautiously. Note that the plasma concentrations of the drug and active metabolite do not stabilise for 7 to 14 days after commencing treatment and after a dosage change. During treatment, the efficacy and tolerability of Anafranil must be judged by keeping the patients under close surveillance. Depression, obsessive-compulsive disorders and phobias: Start treatment with one tablet of 25 mg 2 or 3 times daily. Raise the daily dosage stepwise, e.g. 25 mg every few days, (depending on how the medication is tolerated) to 4 to 6 tablets of 25 mg. Once a distinct improvement has set in, adjust the daily dosage to a maintenance level averaging 2 to 4 tablets of 25 mg. 1 Cataplexy accompanying narcolepsy: Anafranil should be given orally in a daily dose of 25 to 75 mg.
    [Show full text]